Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease

NCT00260793 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

20

Enrollment

INDIV

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Ropinirole Hydrochloride

Sponsor

Agarwal, Pinky, M.D.

Collaborators

[object Object]
[object Object]